PIONEER-HF
2019
Comparison of Sacubitril/Valsartan versus Enalapril on Effect on NT-proBNP in Patients Stabilized from an Acute Heart Failure Episode
In 881 patients hospitalised for acute decompensated HFrEF, in-hospital initiation of sacubitril/valsartan lowered NT-proBNP more than enalapril.
Result
ratio0.7195% CI 0.63-0.81 · P < 0.001
Also reported: With no excess of key safety events.
- Subtopic
- ARNI
- Design
- Double-blind active-controlled RCT
- Relevance
- Important: one of several pillars.
- Source
- Velazquez EJ, et al. N Engl J Med. 2019;380(6):539-548.doi 10.1056/NEJMoa1812851
Discussion & critique
Biomarker (NT-proBNP) primary endpoint rather than clinical outcomes, and short 8-week duration. Demonstrated safe in-hospital initiation of ARNI in stabilised acute HFrEF, shifting practice toward starting sacubitril/valsartan before discharge.